LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,605 | -16.3% | 4,750 | 0.0% | 0.00% | – |
| Q2 2023 | $6,698 | -6.0% | 4,750 | 0.0% | 0.00% | – |
| Q1 2023 | $7,125 | +28.2% | 4,750 | 0.0% | 0.00% | – |
| Q4 2022 | $5,558 | +11.2% | 4,750 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -37.5% | 4,750 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | +14.3% | 4,750 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -41.7% | 4,750 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | 0.0% | 4,750 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -14.3% | 4,750 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | – | 4,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 4,735,990 | $8,335,000 | 3.63% |
| BROADWOOD CAPITAL INC | 34,005,379 | $59,849,000 | 3.55% |
| Prescott General Partners LLC | 1,851,851 | $3,259,000 | 0.14% |
| Strategic Wealth Investment Group, LLC | 66,917 | $118,000 | 0.07% |
| Laidlaw Wealth Management LLC | 170,658 | $300,000 | 0.06% |
| Humankind Investments LLC | 26,737 | $47,000 | 0.05% |
| DAFNA Capital Management LLC | 80,000 | $141,000 | 0.04% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $79,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 680,839 | $1,198,000 | 0.02% |
| Allegheny Financial Group LTD | 20,000 | $35,000 | 0.02% |